• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分离循环免疫复合物中人类低密度脂蛋白修饰形式的免疫测定。

Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.

作者信息

Virella Gabriel, Colglazier Joan, Chassereau Charlyne, Hunt Kelly J, Baker Nathaniel L, Lopes-Virella Maria F

机构信息

Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

J Immunoassay Immunochem. 2013;34(1):61-74. doi: 10.1080/15321819.2012.683500.

DOI:10.1080/15321819.2012.683500
PMID:23323982
Abstract

Modified lipoproteins are able to induce inflammatory reactions through innate immunity pathways and are immunogenic, leading to an autoimmune response that results in the formation of proinflammatory immune complexes. The measurement of circulating oxidized lipoproteins and corresponding antibodies has, therefore, been proposed as an approach to assess the risk for complications in patients with diabetes and for the risk of cardiovascular disease in the general population. However, the majority of modified low density lipoprotein (LDL) in the peripheral circulation exists in the form of immune complexes, and this is a significant obstacle for the measurement of modified LDL and the corresponding antibodies. In this manuscript, we describe in detail the methodology developed by our group for isolation and fractionation of circulating immune complexes (IC), allowing the accurate assay of different LDL modifications. This approach has resulted in several studies showing that the levels of modified LDL are risk factors with a stronger association to diabetic retinopathy, nephropathy, and macrovascular disease. Ongoing research is focused on evaluating the predictive power of modified LDL levels for the development or progression of atherosclerotic cardiovascular disease in other patient populations and on the simplification of the assay to make it more applicable to diagnostic laboratories.

摘要

修饰脂蛋白能够通过固有免疫途径诱导炎症反应,且具有免疫原性,会引发自身免疫反应,进而导致促炎性免疫复合物的形成。因此,循环氧化脂蛋白及相应抗体的检测已被提议作为评估糖尿病患者并发症风险以及普通人群心血管疾病风险的一种方法。然而,外周循环中大多数修饰的低密度脂蛋白(LDL)以免疫复合物的形式存在,这是检测修饰LDL及相应抗体的一个重大障碍。在本手稿中,我们详细描述了我们团队开发的用于分离和分级循环免疫复合物(IC)的方法,该方法能够准确测定不同的LDL修饰。这种方法已促成多项研究表明,修饰LDL水平是与糖尿病视网膜病变、肾病和大血管疾病关联更强的危险因素。正在进行的研究聚焦于评估修饰LDL水平对其他患者群体动脉粥样硬化性心血管疾病发生或进展的预测能力,以及简化检测方法使其更适用于诊断实验室。

相似文献

1
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.分离循环免疫复合物中人类低密度脂蛋白修饰形式的免疫测定。
J Immunoassay Immunochem. 2013;34(1):61-74. doi: 10.1080/15321819.2012.683500.
2
Soluble LDL-immune complexes in type 2 diabetes and vascular disease.2型糖尿病与血管疾病中的可溶性低密度脂蛋白免疫复合物
Horm Metab Res. 2002 Apr;34(4):196-201. doi: 10.1055/s-2002-26706.
3
High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.高水平的晚期糖基化终末产物修饰的低密度脂蛋白(AGE-LDL)以及与循环免疫复合物中氧化型低密度脂蛋白(oxLDL)和晚期糖基化终末产物修饰的低密度脂蛋白(MDA-LDL)所表达的丙二醛-赖氨酸表位发生反应的IgG抗体可预测2型糖尿病患者的大量白蛋白尿。
J Diabetes Complications. 2016 May-Jun;30(4):693-9. doi: 10.1016/j.jdiacomp.2016.01.012. Epub 2016 Jan 14.
4
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.氧化型低密度脂蛋白抗体和含低密度脂蛋白的免疫复合物作为糖尿病患者冠状动脉疾病的危险因素。
Clin Immunol. 1999 Feb;90(2):165-72. doi: 10.1006/clim.1998.4631.
5
Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.氧化型低密度脂蛋白自身抗体:与糖尿病患者低密度脂蛋白脂肪酸组成的关系
Diabet Med. 1997 Sep;14(9):741-7. doi: 10.1002/(SICI)1096-9136(199709)14:9<741::AID-DIA468>3.0.CO;2-A.
6
Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.抗氧化型低密度脂蛋白和C反应蛋白的自身抗体与女性糖尿病和心肌梗死相关。
Clin Sci (Lond). 2001 Nov;101(5):523-31.
7
Development of capture assays for different modifications of human low-density lipoprotein.针对人低密度脂蛋白不同修饰的捕获检测方法的开发。
Clin Diagn Lab Immunol. 2005 Jan;12(1):68-75. doi: 10.1128/CDLI.12.1.68-75.2005.
8
Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.修饰的低密度脂蛋白和含脂蛋白的循环免疫复合物作为动脉粥样硬化和1型糖尿病大血管疾病的诊断和预后生物标志物。
Int J Mol Sci. 2014 Jul 21;15(7):12807-41. doi: 10.3390/ijms150712807.
9
The immunogenicity of modified lipoproteins.修饰脂蛋白的免疫原性。
Ann N Y Acad Sci. 2005 Jun;1043:367-78. doi: 10.1196/annals.1333.043.
10
[Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].[非胰岛素依赖型糖尿病患者对修饰型低密度脂蛋白的免疫反应]
Rev Med Chil. 1997 Aug;125(8):879-85.

引用本文的文献

1
ASSOCIATIONS BETWEEN ACCELERATED ATHEROSCLEROSIS, OXIDIZED LDL IMMUNE COMPLEXES, AND IN VITRO ENDOTHELIAL DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS.在系统性红斑狼疮中,动脉粥样硬化加速、氧化型 LDL 免疫复合物与体外内皮功能障碍之间的关系。
Trans Am Clin Climatol Assoc. 2020;131:157-177.
2
Immune Complexes and the Risk of CVD in Type 1 Diabetes.免疫复合物与 1 型糖尿病患者心血管疾病风险
Diabetes. 2019 Sep;68(9):1853-1860. doi: 10.2337/db19-0358. Epub 2019 Jun 19.
3
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
辛伐他汀有效降低小LDL-IgG免疫复合物水平:一种超越降脂作用的治疗特性。
PLoS One. 2016 Feb 3;11(2):e0148210. doi: 10.1371/journal.pone.0148210. eCollection 2016.